The correlation between ejection fraction values and blood urea nitrogen levels and blood urea nitrogen/creatinine ratios in heart failure
Keywords:
heart failure, blood urea nitrogen, creatinineAbstract
Background: Heart failure is a condition with high mortality characterized by a decrease in the heart's ability to pump blood. Decreased EF can affect renal perfusion and trigger renal dysfunction, as reflected in increased BUN and altered BUN/Cr ratio. Therefore, the relationship between EF and these biochemical parameters is important to support clinical assessment in patients with heart failure. The purpose of this study was to determine the correlation between EF values and BUN levels and BUN/Cr ratio in patients with heart failure.
Materials and Methods: An analytical observational study with a cross-sectional design involving 456 patients with heart failure at Wahidin Sudirohusodo Hospital, Makassar, Indonesia. EF values were obtained from echocardiography, and BUN and creatinine levels were measured through laboratory tests.
Result: Patients with HFrEF showed significantly higher mean BUN levels compared to HFmrEF and HFpEF (55.08 ± 38.49 mg/dL vs. 50.87 ± 35.31 mg/dL vs. 37.78 ± 21.50 mg/dL, respectively; p < 0.001). HFrEF patients showed significantly higher mean BUN/Cr ratios compared to HFmrEF and HFpEF (48.94 ± 28.10 mg/dL vs. 45.56 ± 24.63 mg/dL vs. 41.25 ± 22.41 mg/dL, respectively; p = 0.04).
Conclusion: Patients with heart failure with low ejection fraction (HFrEF) had the highest BUN levels and BUN/creatinine ratios compared to the HFmrEF and HFpEF groups. These findings confirm that renal dysfunction is more common in patients with low ejection fraction, and monitoring BUN parameters and BUN/creatinine ratios can be important indicators in assessing the severity of heart failure.
References
1. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895–e1032. doi: 10.1161/CIR.0000000000001063.
2. Bozkurt B, Ahmad T, Alexander K, et al. HF STATS 2024: heart failure epidemiology and outcomes statistics An Updated 2024 Report from the Heart Failure Society of America.J Card Fail. 2025;31(1):66–116. doi: 10.1016/j.cardfail.2024.07.001.
3. Feng J, Zhang Y, Zhang J. Epidemiology and burden of heart failure in Asia. JACC Asia. 2024;4(4):249–64. doi: 10.1016/j.jacasi.2024.01.013.
4. Djafar DU, Luntungan M, Panda AL, Setiawan S. Relationship between blood urea level and left ventricular ejection fraction (LVEF) in patients with ST-elevation myocardial infarction. e-CliniC. 2022;10(2):306–10. doi: 10.35790/ecl.v10i2.39101.
5. Sakr ARM, Gomaa GFE, Wasif SME, Eladawy AHH. The prognostic role of urea-to-creatinine ratio in patients with acute heart failure syndrome: a case–control study. Egypt Heart J. 2023;75(1):78. doi: 10.1186/s43044-023-00404-y.
6. Moreira G, Avila DX, Candia AM, Scaramussa VD, Villacorta H. Role of urea to creatinine ratio in prediction of outcomes in chronic heart failure. Eur Heart J. 2024;45(Supplement_1):ehae666-980. doi: 10.1093/eurheartj/ehae666.980.
7. Zhou Y, Zhao Q, Liu Z, Gao W. Blood urea nitrogen/creatinine ratio in heart failure: a systematic review and meta-analysis. PLoS One. 2024;19(5):e0303870. doi: 10.1371/journal.pone.0303870.
8. Parhizkar Roudsari P, Behnoush AH, Moradi A, et al Prognostic value of renal function biomarkers in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Circulation. 2024;150(Suppl 1):A4140673. doi: 10.1161/circ.150.suppl_1.4140673.
9. Abofrekha B, Jdaidani J, Agarwal A, Shadi M, Rojas-Marte G. BUN to albumin ratio: raising the BAR for heart failure prognosis. J Am Coll Cardiol. 2025;85(12_Supplement):1354. doi: 10.1016/S0735-1097(25)01838-8.
10. Kumar A, Iqbal U, Amin SB, et al. Evaluating the safety and effectiveness of tolvaptan in patients with heart failure and renal impairment: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2025;81(2):203–16. doi: 10.1007/s00228-024-03778-3.
11. Oswald AS, Hussain MS, Win ML, et al. Blood urea monitoring in heart failure patients - an predictor of mortality. Eur Heart J. 2024;45(Supplement_1):ehae666-988. doi: 10.1093/eurheartj/ehae666.988.
12. Yingchoncharoen T, Phrommintikul A, Buakhamsri A, et al. Nationwide analysis of mortality and causes of death in heart failure: updated insights from the Thai Heart Failure Registry (THFR). Eur Heart J. 2024;45(Supplement_1):ehae666-942. doi: 10.1093/eurheartj/ehae666.942.
13. El Amrawy AM. 300.08 Clinical comparative study assessing the effect of ivabradine on neopterin and NT-Pro BNP against standard treatment in chronic heart failure patients. J Am Coll Cardiol Intv. 2025;18(4_Supplement):S59. doi: 10.1016/j.jcin.2025.01.226.
14. İnce ME, Şirali SK, Bulucu MF, Çorakcı A. Relation between NT-proBNP and serum sodium based on glomerular filtration rate: NT-proBNP and Sodium. J Eur Intern Med Prof. 2025;3(1):6–12. doi: 10.5281/zenodo.14692905.
15. Yu L, Sun J, Liu X. A retrospective study of the association between serum uric acid and risk of coronary heart disease complicated with different types of chronic heart failure. Eur J Med Res. 2025;30(1):146. doi: 10.1186/s40001-025-02403-y.
16. Fukuta Y, Tanaka S, Kawaguchi T, et al. Association of changes in the left ventricular ejection fraction with physical function characteristics and survival in patients with heart failure. Res Sq [Preprint]. 2024. doi: 10.21203/rs.3.rs-4846304/v1.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Daniel Francis Jaury, Idar Mappangara, Haerani Rasyid, Syakib Bakri, Andi Makbul Aman, Andi Alfian Zainuddin
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
